Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis and IBM form breast cancer research partnership

June 7, 2017
Research and Development Novartis, ibm

Novartis is to join forces with tech giant IBM and its Watson Health platform to tackle advanced breast cancer with …

News
novartis_window

Mounting US pricing pressures cutting into quarterly sales, Novartis admits

May 31, 2017
Research and Development, Sales and Marketing Novartis, Sandoz

Novartis has revealed that increasing pressure on pricing in the US has impacted its second-quarter business, cutting into sales generated …

News
novartis_outside_1

FDA approves Novartis’ Zykadia as first-line lung cancer treatment

May 30, 2017
Manufacturing and Production, Sales and Marketing FDA, NSCLC, Novartis

The FDA has announced it has approved Novartis’ Zykadia (ceritinib) as a first line treatment in the expanded indication of …

News

Novartis cuts 500 traditional roles for 350 ‘high-tech’ ones

May 22, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Novartis

Novartis has announced a restructure within the company which will lead to the transfer or loss of 500 traditional production …

News

GSK mulls $8 billion healthcare consolidation deal

May 15, 2017
Sales and Marketing GSK, Novartis

When GSK and Novartis first agreed their business swap and healthcare joint venture, it was seen as marking a shift …

News
2000px-flag_of_pakistan

Novartis signs drug access deal with Pakistan government

May 12, 2017
Medical Communications, Sales and Marketing Islamabad, Novartis, Pakistan, market access

Pakistan’s Ministry of National Health Services, Regulations and Coordination has signed an agreement with Novartis to improve access to medicines …

News
dr_sonia_quaratino

Kymab instates first Chief Medical Officer

May 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab

Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …

Appointment
shutterstock_212432119

Allergan and Novartis join forces to develop NASH combo therapy

April 18, 2017
Manufacturing and Production, Research and Development Allergan, Novartis, nash

Allergan and Novartis have announced a new partnership to conduct a clinical trial in the treatment area of non-alcoholic steatohepatitis …

News
novartis_outside_1

Novartis takes on dry-eye market with drug in-licensing move

April 7, 2017
Medical Communications, Sales and Marketing Lubris, Novartis, dry eye

Novartis has announced that its eyecare-focused division Alcon has in-licensed dry-eye drug ECF843 from US firm Lubris for ophthalmic indications …

News
european_commission

Novartis combo expands into lung cancer with EU approval

April 4, 2017
Manufacturing and Production, Sales and Marketing NSCLC, Novartis, Tafinlar, mekinist

Novartis has announced that its Tafinlar (dabrafenib) and Mekinist (trametinib) drug combo has been approved by the European Commission (EC) …

News
novartis_outside_1

Novartis investigational CAR-T therapy gets FDA priority review

March 30, 2017
Sales and Marketing CTL019, FDA, Novartis, leukaemia

Novartis’ investigational chimeric antigen receptor T cell (CAR-T) therapy CTL019 (tisagenlecleucel-T) has been awarded has been awarded priority review by …

News
ema_building_face_web

EMA recommends suspension of 331 drugs over testing concerns

March 28, 2017
Manufacturing and Production, Sales and Marketing Aurobindo, Micro Therapeutic Research Labs, Novartis, Sandoz

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has called for the suspension of 331 drugs due to …

News
heartbeat

Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017
Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …

News

Novartis’ psoriasis drug allows some patients to go into remission

March 21, 2017
Research and Development Cosentyx, Novartis, psoriasis

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …

News
shutterstock_274590824

Ex-Novartis employee found not guilty of deceitful drug advertising

March 17, 2017
Medical Communications, Sales and Marketing Diovan, Novartis, legal

A Tokyo court has ruled finding ex-Novartis employee Nobuo Shirahashi and the company’s Tokyo-based sales arm Novartis Pharma KK not …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025